Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths September 8, 2017 Russell Maas Add Your Comments Federal health officials have placed a hold on three clinical trials designed to test the combination of advanced lung cancer treatments with various other forms of cancer drugs for treatment of multiple myeloma, after reports of several patient deaths with a similar drug. Bristol-Myers Squibb issued a press release on September 6, announcing that the FDA has halted the studyes that were testing Opdivo in conjunction with Celgene’s Revlimid or Pomalyst medications, which are the same medications used in conjunction with Keytruda multiple myeloma studies that resulted in several patient deaths. Opdivo and Keytruda are similar, competing cancer drugs known as immune checkpoint inhibitors. Multiple myeloma is a form blood cancer related to lymphoma and leukemia, in which Merck’s Keytruda and Bristol-Myers Squibb’s Opdivo were being tested in separate clinical trials, pairing them with the chemotherapy drug dexamethasone and either Celgene’s Revlimid or Pomalyst, as a potential new form of treatment. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Following patient deaths in two Keytruda clinical studies, the FDA halted any further advancement and new patient registration for both companies, out of an abundance of caution. The agency said the risks of severe adverse events, including death, appeared to outweigh any benefits of using the drug combinations to treat multiple myeloma. The Opdivo trials are being halted due to the close similarities between Keytruda and Opdivo. The FDA is ordering patients currently taking part in the Opdivo trials to continue with the regimens, as long as they are experiencing clinical benefit. However, no new patients can enroll in the studies. Opdivo studies affected by the FDA’s decision include CheckMate-602, CheckMate-039, and CA204142. The FDA previously issued a safety alert for two Keytruda studies on August 31, 2017 after finding the medication used in combination with some other medications to treat multiple myeloma may be deadly for some patients. The FDA warning came after data from the KEYNOTE-183 trial, which involved about 250 patients, indicated that patients given Keytruda had a 61% increased risk of death, with 29 deaths in the Keytruda arm of the clinical trial, compared to only 21 deaths among the control subjects. Furthermore, the Keytruda KEYNOTE-185 clinical trial, involving about 300 patients, saw an even higher risk, with more than twice as many Keytruda patients dying than those in the control group, 19 to 9. That trial also showed that 54% of the patients given a Keytruda-based drug combination had a 54% chance of severe adverse health effects, compared to only 39% in the control group. The FDA is asking healthcare professionals and patients who experience any adverse events or side effects during Keytruda treatment to report them to the FDA’s MedWatch Adverse Event Reporting Program. Tags: Bristol Myers Squibb, Cancer, Clinical Trials, Keytruda, Merck, Multiple Myeloma, Opdivo More Lawsuit Stories Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks June 20, 2025 Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions June 20, 2025 New Study Links Ultra-Processed Foods Intake With Multiple Adverse Health Effects June 20, 2025 4 Comments Sue May 2, 2020 In 2012 my husband was diagnosed with Renal Cell Carsanoma for which there is no chemo treatment. In 2019 he was told by his Oncologist that he may want to consider immuno therapy and after one infusion of Opdivo the drug started to attack all his vital organs and ultimately caused his death in May 2019. We were not told at the time of treatment that this drug was so new that even the doctors did not know how to reverse the horrific side effects. They were brutal!! I feel my husband would still be alive today if he had not taken Opdivo!!! His Oncologist agreed that his cancer was not what he died from it was that toxic drug. Sharon January 30, 2020 My husband was scheduled for 26 treatments after # 4 shut down his pituitary gland , almost killed him. Now has lifelong effects from this drug. Use extreme caution when advised to take this as a treatment. Debra July 25, 2019 On the fourth day after my husband’s second Opdivo infusion, he was in the hospital with a glucose reading of 1,100. He is now a type 1 diabetic and has had severe diarrhea for over 5 months. Please do not take this drug. It has life altering consquences. cv September 26, 2017 I am gut sick about this treatment. My husband had two chemo treatments and then was changed to Opdivo. It was not clinical trial. Why on earth would a pharm. company allow their drug to be given to someone without a spleen, since it works with your immune system. They did not think twice about helping with funding, do they educate the doctors. There is no doubt in my mind, my husband would still be here if not for the side effects and lack of information given to us on this drug. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)